Literature DB >> 22993343

Prediction of recurrence after complete resection in patients with NSCLC.

Hidetaka Uramoto1, Fumihiro Tanaka.   

Abstract

A proportion of lung cancer patients develop recurrence, even after curative resection. This study reviewed the literature, focusing on the key words: recurrence, relapse, relapse-free survival, disease-free survival (DFS), surgery, and non-small cell lung cancer (NSCLC), not overall survival (OS) to evaluate the post-operative risk factors for tumor recurrence after surgery. This article reviews the current status and progress on this subject.

Entities:  

Mesh：

Year:  2012        PMID： 22993343

Source DB:  PubMed          Journal:  Anticancer Res        ISSN： 0250-7005            Impact factor:   2.480


  16 in total

1.  Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma.

Authors:  Jian Zhou; Francisco Sanchez-Vega; Raul Caso; Kay See Tan; Whitney S Brandt; Gregory D Jones; Shi Yan; Prasad S Adusumilli; Matthew Bott; James Huang; James M Isbell; Smita Sihag; Daniela Molena; Valerie W Rusch; Walid K Chatila; Natasha Rekhtman; Fan Yang; Marc Ladanyi; David B Solit; Michael F Berger; Nikolaus Schultz; David R Jones
Journal:  Clin Cancer Res       Date:  2019-08-27       Impact factor: 12.531

Review 2.  Recurrence after surgery in patients with NSCLC.

Authors:  Hidetaka Uramoto; Fumihiro Tanaka
Journal:  Transl Lung Cancer Res       Date:  2014-08

3.  Prediction of Two-Year Recurrence-Free Survival in Operable NSCLC Patients Using Radiomic Features from Intra- and Size-Variant Peri-Tumoral Regions on Chest CT Images.

Authors:  Soomin Lee; Julip Jung; Helen Hong; Bong-Seog Kim
Journal:  Diagnostics (Basel)       Date:  2022-05-25

Review 4.  Toll-like receptors: exploring their potential connection with post-operative infectious complications and cancer recurrence.

Authors:  S D Gowing; J J Cool-Lartigue; J D Spicer; A J E Seely; L E Ferri
Journal:  Clin Exp Metastasis       Date:  2020-01-23       Impact factor: 5.150

5.  Value of Positron Emission Tomography/Computed Tomography (PET-CT) in Suspected Non-small Cell Lung Cancer Recurrence and Impact on Patient Management.

Authors:  Nermina Beslic; Amera Sadija; Timur Ceric; Renata Milardovic; Sejla Ceric; Semra Cavaljuga
Journal:  Acta Inform Med       Date:  2016-07-16

Review 6.  The Role of PET/CT Molecular Imaging in the Diagnosis of Recurrence and Surveillance of Patients Treated for Non-Small Cell Lung Cancer.

Authors:  Julio Francisco Jiménez-Bonilla; Remedios Quirce; I Martínez-Rodríguez; María De Arcocha-Torres; José Manuel Carril; Ignacio Banzo
Journal:  Diagnostics (Basel)       Date:  2016-09-30

7.  Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer.

Authors:  Wenwei Hu; Yang Yang; Longzhen Zhang; Jianxin Yin; Jingwei Huang; Lei Huang; Hua Gu; Gening Jiang; Jianmin Fang
Journal:  Cancer Med       Date:  2017-04-05       Impact factor: 4.452

8.  The prognostic value of a Methylome-based Malignancy Density Scoring System to predict recurrence risk in early-stage Lung Adenocarcinoma.

Authors:  Lu Yang; Jing Zhang; Guangjian Yang; Haiyan Xu; Jing Lin; Lin Shao; Junling Li; Changyuan Guo; Yanru Du; Lei Guo; Xin Li; Han Han-Zhang; Chenyang Wang; Shannon Chuai; Junyi Ye; Qiaolin Kang; Hao Liu; Jianming Ying; Yan Wang
Journal:  Theranostics       Date:  2020-06-18       Impact factor: 11.556

9.  Identification of recurrence-associated microRNAs in stage I lung adenocarcinoma.

Authors:  Jongmin Sim; Yeseul Kim; Hyunsung Kim; Su-Jin Shin; Dong-Hoon Kim; Seung Sam Paik; Kiseok Jang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

Review 10.  Surgery after neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer.

Authors:  Caroline Huynh; Logan A Walsh; Jonathan D Spicer
Journal:  Transl Lung Cancer Res       Date:  2021-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.